iifl-logo-icon 1

Shilpa Medicare Ltd Key Ratios

830.85
(-3.74%)
Oct 21, 2024|03:33:40 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-0.74

15.09

1.24

8.75

Op profit growth

-17.35

35.54

-5.32

7.05

EBIT growth

-18.21

31.6

-8.53

9.26

Net profit growth

-5.36

48.37

-2.17

-0.7

Profitability ratios (%)

OPM

20.15

24.2

20.55

21.98

EBIT margin

17.51

21.25

18.58

20.57

Net profit margin

16.39

17.19

13.34

13.8

RoCE

7.44

12.13

10.92

14.14

RoNW

2.63

3.23

2.53

3.29

RoA

1.74

2.45

1.96

2.37

Per share ratios (₹)

EPS

17.93

18.96

12.62

13.04

Dividend per share

1.1

1.1

0.7

0.6

Cash EPS

11.5

13.78

8.34

9.6

Book value per share

181.37

163.05

133.08

123.16

Valuation ratios

P/E

18.61

12.89

36.84

48.75

P/CEPS

29.01

17.73

55.73

66.21

P/B

1.84

1.49

3.49

5.16

EV/EBIDTA

16.26

9.87

21.25

27.41

Payout (%)

Dividend payout

0

0

6.52

5.38

Tax payout

-35.93

-17.77

-23.55

-26.74

Liquidity ratios

Debtor days

94.02

93.88

90.5

59.84

Inventory days

110.02

83.44

87.61

82.56

Creditor days

-59.6

-62.73

-64.59

-64.03

Leverage ratios

Interest coverage

-7.21

-42.33

-55.09

-51.13

Net debt / equity

0.48

0.25

0.1

0.14

Net debt / op. profit

3.97

1.57

0.72

0.82

Cost breakup (₹)

Material costs

-30.04

-30.58

-45.11

-47.71

Employee costs

-26.11

-21.65

-18.9

-16.41

Other costs

-23.68

-23.54

-15.42

-13.88

Shilpa Medicare : related Articles

Top 10 stocks for today - 4th October, 2024
4 Oct 2024|08:46 AM

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, Bank of Baroda, HDFC Bank, etc.

Read More
Shilpa Medicare submits new drug application with USFDA
4 Sep 2024|08:59 PM

According to the firm, the NDA submission package is based on three clinical trials, many pre-clinical investigations.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp